Loading clinical trials...

COMPLETEDPhase 2NCT00968851

Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia

This study is being conducted to determine the safety and effect on cognitive function of two different doses of an investigational medication, EVP-6124, in individuals with schizophrenia who are on c...

Lead sponsor: FORUM Pharmaceuticals Inc•14 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 3

A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

NCT06894212 · Schizophrenia

RECRUITINGNA

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine

NCT06003036 · Schizophrenia, Schizoaffective Disorder

RECRUITINGPhase 2

Synbiotic Compound to Reduce Symptoms of Schizophrenia

NCT04226898 · Schizophrenia, Schizoaffective Disorder

RECRUITINGPhase 1/2

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

NCT05386108 · Breast Neoplasms, Brain Neoplasms, and more

RECRUITINGPhase 4

Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?

NCT07109245 · Brain Insulin Sensitivity, Healthy Controls, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 25, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment317

Start dateDec 2009

Last updatedApr 25, 2014

Condition

Schizophrenia Central Nervous System Diseases Cognition

Locations shown

Intergrated Medical and Behavioral Associates

Glendale, California

Excell Research

Oceanside, California

University of California, San Diego

San Diego, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 25, 2014Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions